“Large molecule” therapies, tailored to home in on otherwise untreatable ills, have become medicine‘s hottest commodity.
The Price of Personalization
Tailoring treatments, patient by patient, can achieve remarkable results. But can we afford to make every disease rare?
The Trouble with Targeting Treatments
Researchers are working to develop diagnostic tests to determine who is eligible for targeted therapies, but red tape and limited expertise stand in the way.